Analyzing Options to Cover Prescription Drugs for Medicare Beneficiaries PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Analyzing Options to Cover Prescription Drugs for Medicare Beneficiaries PDF full book. Access full book title Analyzing Options to Cover Prescription Drugs for Medicare Beneficiaries by . Download full books in PDF and EPUB format.
Author:
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 70
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 70
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Ways and Means
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 184
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Ways and Means
Publisher:
ISBN:
Category : Insurance, Pharmaceutical services
Languages : en
Pages : 130
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: United States. Congress. House. Committee on Ways and Means
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 128
Get Book Here
Book Description
Author: Nicole K. Delgado (Graduate student)
Publisher:
ISBN:
Category : Medical care, Cost of
Languages : en
Pages : 0
Get Book Here
Book Description
Abstract: This is a policy analysis of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, commonly referred to as Medicare Part D by Medicare beneficiaries and the wider health care community. Before the enactment and implementation of the policy, prescription drug coverage was not a part of the more extensive Medicare benefits. There are two main objectives of the policy. The first is to offer prescription medication coverage to all eligible beneficiaries. The second is to provide access to needed prescription medications for beneficiaries. The following policy analysis analyzes the impact of the Medicare Part D policy on beneficiaries with chronic medical conditions who may need access to specialty medications and the effect on beneficiaries of color.
Author: Peter Hansel
Publisher:
ISBN:
Category : Insurance, Pharmaceutical services
Languages : en
Pages : 16
Get Book Here
Book Description
Author:
Publisher: World Health Organization
ISBN: 9240011870
Category : Business & Economics
Languages : en
Pages : 70
Get Book Here
Book Description
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309158060
Category : Medical
Languages : en
Pages : 442
Get Book Here
Book Description
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Author: Anna Cook
Publisher:
ISBN: 9781457856631
Category :
Languages : en
Pages : 48
Get Book Here
Book Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In FY 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10% of net federal spending for Medicare. A combination of broader trends in the prescription drug market and lower-than-expected enrollment in Part D has contributed to much lower spending for the program than projected when the MMA became law in 2003. This report examines the federal budgetary cost and competitive design of Medicare Part D and compares Medicare Part D and Medicaid Fee for Service. Figures and tables. This is a print on demand report.
